Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo

Motoo Nagane(Kyowa Kirin (Japan)), Yoshiaki Shiokawa(Kyowa Kirin (Japan))

Neuro-Oncology

February 11, 2010

10.1093/neuonc/nop069

Cited by 24

Related Papers

Selection of Treatment Modality in Ruptured Cerebral Aneurysms : A Comment on the International Subarachnoid Aneurysm Trial

|Japanese Journal of Neurosurgery|2006|1